<DOC>
	<DOCNO>NCT02100319</DOCNO>
	<brief_summary>The purpose study evaluate efficacy azilsartan tablet ( Azilva Tablets ) patient hypertension complicate diabetes mellitus whose blood pressure sufficiently reduce monotherapy angiotensin II receptor blocker ( ARBs ) azilsartan , routine clinical practice</brief_summary>
	<brief_title>Azilsaltan Tablets ( Azilva Tablets ) Special Drug Use Surveillance `` Hypertension Complicated Diabetes ``</brief_title>
	<detailed_description>This study design evaluate efficacy azilsartan tablet ( Azilva Tablets ) patient hypertension complicate diabetes mellitus whose blood pressure sufficiently reduce monotherapy ARBs , azilsartan , daily medical practice . Subject enrollment start April 1 , 2014 . The usual dosage adult 20 mg azilsartan administer orally daily . The dose adjust accord patient 's age condition . The maximum daily dose 40 mg .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Patients hypertension meet follow criterion enrol : 1 . Patients complication diabetes mellitus 2 . Patients monotherapy ARBs ( azilsartan ) antihypertensive treatment ( Patients continue monotherapy ARB product least 8 week time Step1* subject enrollment continue treatment first administration Azilva Tablets ) 3 . Patients systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure 80 ≥ mmHg examination perform medical institution 4 . Patients outpatient 5 . Patient keep regular lifestyle whose usual waking time 4 a.m. 9:30 a.m. For surveillance , subject enrollment perform two divided step : Step1 ( hospital visit prescription Azilva Tablets ) Step2 ( time prescription Azilva Tablets ) . Patients contraindication azilsartan</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>